Journal of Proteome Research,
Год журнала:
2024,
Номер
unknown
Опубликована: Окт. 22, 2024
Recent
advancements
in
single-cell
(sc)
resolution
analyses,
particularly
sc
transcriptomics
and
proteomics,
have
revolutionized
our
ability
to
probe
understand
cellular
heterogeneity.
The
study
of
metabolism
through
small
molecules,
metabolomics,
provides
an
additional
level
information
otherwise
unattainable
by
or
proteomics
shedding
light
on
the
metabolic
pathways
that
translate
gene
expression
into
functional
outcomes.
Metabolic
heterogeneity,
critical
health
disease,
impacts
developmental
outcomes,
disease
progression,
treatment
responses.
However,
dedicated
approaches
probing
metabolome
not
reached
maturity
other
omics
technologies.
Over
past
decade,
innovations
metabolomics
addressed
some
practical
limitations,
including
cell
isolation,
signal
sensitivity,
throughput.
To
fully
exploit
their
potential
biological
research,
however,
remaining
challenges
must
be
thoroughly
addressed.
Additionally,
integrating
with
orthogonal
techniques
will
required
validate
relevant
results
gain
systems-level
understanding.
This
perspective
offers
a
broad-stroke
overview
recent
mass
spectrometry
(MS)-based
advancements,
focusing
ongoing
from
biologist's
viewpoint,
aimed
at
addressing
pertinent
innovative
questions.
we
emphasize
use
showcase
systems
these
sophisticated
methodologies
are
apt
explore.
Biomolecules,
Год журнала:
2025,
Номер
15(2), С. 248 - 248
Опубликована: Фев. 8, 2025
The
type
I
protein
kinase
PERK
is
an
endoplasmic
reticulum
(ER)
transmembrane
that
plays
a
multifaceted
role
in
cancer
development
and
progression,
influencing
tumor
growth,
metastasis,
cellular
stress
responses.
activation
of
represents
one
the
three
signaling
pathways
induced
during
unfolded
response
(UPR),
which
triggered,
particular,
cells
constitutively
experience
various
intracellular
extracellular
stresses
impair
folding
within
ER.
can
lead
to
both
pro-survival
proapoptotic
outcomes,
depending
on
context
extent
ER
stress.
It
helps
reprogramming
gene
expression
cells,
thereby
ensuring
survival
face
oncogenic
stress,
such
as
replicative
DNA
damage,
also
microenvironmental
challenges,
including
hypoxia,
angiogenesis,
metastasis.
Consequently,
contributes
initiation,
transformation,
adaptation
microenvironment,
chemoresistance.
However,
sustained
cell
proliferation
promote
apoptotic
death
by
interconnected
processes,
mitochondrial
dysfunction,
translational
inhibition,
accumulation
stresses,
specific
induction
multifunctional
factors,
CHOP.
dual
promoting
progression
suppression
makes
it
complex
target
for
therapeutic
interventions.
A
comprehensive
understanding
intricacies
pathway
their
impact
essential
effective
strategies,
particularly
diseases
like
cancer,
where
deregulated
most,
if
not
all,
solid
liquid
tumors.
This
article
provides
overview
knowledge
acquired
from
study
animal
models
lines
cultured
vitro
PERK’s
functions
thus
highlighting
potential
new
avenues
could
this
protein.
Molecular Oncology,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 25, 2025
Chondrosarcomas
are
common
bone
sarcomas
frequently
resistant
to
radiation
and
chemotherapy,
with
high
recurrence
rates,
development
of
metastatic
disease,
death.
Fibrosarcomas
soft
tissue
associated
poor
outcomes.
Translocase
outer
mitochondrial
membrane
receptor
20
(TOMM20)
is
a
protein
cancer
aggressiveness
in
many
subtypes,
but
the
mechanisms
remain
poorly
understood.
Here,
we
studied
effects
TOMM20
overexpression
downregulation
on
redox
state,
oxidative
phosphorylation
(OXPHOS),
tumor
growth
using
fibrosarcoma
chondrosarcoma
models.
increased
OXPHOS,
NADH,
NADPH
reduced
cellular
reactive
oxygen
species
(ROS).
induced
resistance
apoptosis,
including
BCL-2
OXPHOS
complex
IV
inhibitors,
sensitivity
an
I
inhibitor.
Also,
cell
migration
vitro
promoted
vivo.
Conversely,
knocking
down
CRISPR-Cas9
vivo
both
mouse
In
conclusion,
driver
by
apoptosis
resistance,
maintenance
state.
Journal of Translational Medicine,
Год журнала:
2025,
Номер
23(1)
Опубликована: Март 6, 2025
Glioblastoma
(GBM)
patients
frequently
develop
resistance
to
temozolomide
(TMZ),
the
standard
chemotherapy.
While
targeting
cancer
metabolism
shows
promise,
relationship
between
metabolic
perturbation
and
drug
remains
poorly
understood.
We
performed
high-throughput
CRISPR
interference
screens
in
GBM
cells
identify
genes
modulating
TMZ
sensitivity.
Findings
were
validated
using
multiple
cell
lines,
patient-derived
glioma
stem
cells,
clinical
data.
Molecular
mechanisms
investigated
through
transcriptome
analysis,
profiling,
functional
assays.
identified
phosphoglycerate
kinase
1
(PGK1)
as
a
key
determinant
of
Paradoxically,
while
PGK1
inhibition
suppressed
tumor
growth,
it
enhanced
by
inducing
stress.
This
activated
AMPK
HIF-1α
pathways,
leading
DNA
damage
repair
53BP1.
expression
levels
correlated
with
sensitivity
across
models
patient
samples.
Our
study
reveals
an
unexpected
link
stress
chemoresistance,
demonstrating
how
adaptation
can
promote
therapeutic
resistance.
These
findings
caution
against
single-agent
suggest
potential
biomarker
for
response
GBM.
Cells,
Год журнала:
2025,
Номер
14(6), С. 402 - 402
Опубликована: Март 10, 2025
Metabolic
reprogramming
is
a
hallmark
of
cancer,
with
cancer
cells
acquiring
many
unique
metabolic
traits
to
support
malignant
growth,
and
extensive
intra-
inter-tumour
heterogeneity.
Understanding
these
characteristics
presents
opportunities
in
precision
medicine
for
both
diagnosis
therapy.
However,
despite
its
potential,
phenotyping
has
lagged
behind
genetic,
transcriptomic,
immunohistochemical
profiling
clinical
applications.
This
partly
due
the
lack
single
experimental
technique
capable
entire
metabolome,
necessitating
use
multiple
technologies
approaches
capture
full
range
plasticity.
review
examines
repertoire
tools
available
metabolism,
demonstrating
their
applications
preclinical
settings.
It
also
case
studies
illustrating
how
metabolomic
been
integrated
other
omics
gain
insights
into
tumour
biology
guide
treatment
strategies.
information
aims
assist
researchers
selecting
most
effective
highlights
importance
combining
different
techniques
comprehensively
understand
metabolism.
The Innovation Life,
Год журнала:
2025,
Номер
unknown, С. 100128 - 100128
Опубликована: Янв. 1, 2025
<p>Glutamine
is
an
essential
nutrient
that
plays
critical
roles
in
both
normal
physiological
processes
and
disease
pathogenesis.
In
this
study,
we
introduce
a
quantitative
approach
to
trace
the
dynamics
of
glutamine
metabolism
by
monitoring
expression
patterns
glutaminase
(GLS)
its
two
splicing
isoforms,
whose
coding
products
exhibit
distinct
catalytic
activities.
This
can
be
seamlessly
integrated
with
PCR
(qPCR),
conventional
bulk
RNA
sequencing,
emerging
single-cell
sequencing
technologies.
We
identified
key
temporal
during
embryonic
development
stem
cell
differentiation.
Additionally,
characterized
alterations
across
various
states
response
drug
treatments.
cancer,
highly
variable
tumor
types
associated
T-cell
exhaustion
within
microenvironment,
as
well
metastatic
potential
circulating
cells.
Furthermore,
aberrant
was
detected
peripheral
blood
analytes
from
cancer
patients,
suggesting
for
non-invasive
diagnosis.
Our
findings
demonstrate
utility
tracing
investigating
cellular
processes,
mechanisms,
therapeutic
responses,
application
translational
medicine.</p>
Biomedicines,
Год журнала:
2025,
Номер
13(3), С. 707 - 707
Опубликована: Март 13, 2025
Backgroung/objectives:
Diffuse
large
B-cell
lymphoma
(DLBCL)
is
the
most
frequent
subtype
of
malignant
and
a
heterogeneous
disease
with
various
gene
chromosomal
abnormalities.
The
development
novel
therapeutic
treatments
has
improved
DLBCL
prognosis,
but
patients
early
relapse
or
refractory
have
poor
outcome
(with
mortality
around
40%).
Metabolic
reprogramming
hallmark
cancer
cells.
Fatty
acid
(FA)
metabolism
frequently
altered
in
cells
recently
emerged
as
critical
survival
path
for
cell
survival.
Methods:
We
first
performed
metabolic
characterization
an
extended
panel
lines,
including
lipid
droplet
content.
Then,
we
investigated
effect
drugs
targeting
FA
on
Further,
studied
how
combination
either
mitochondrial
mTOR
pathway
impacts
death.
Results:
Here,
reveal,
using
lines
characterized
by
their
status,
that
induces
massive
death
regardless
OxPhos
BCR/glycolytic
subtype.
drives
resistance
induced
stress
upon
treatment
metformin
L-asparaginase,
two
FDA-approved
antimetabolic
drugs.
Interestingly,
combining
inhibition
oncogenic
strongly
potentiates
Conclusion:
Altogether,
our
data
highlight
central
role
played
survival,
independently
subtype,
provide
framework
use
this
vulnerability
to
overcome
patients.
Research Square (Research Square),
Год журнала:
2025,
Номер
unknown
Опубликована: Апрель 11, 2025
Abstract
Metabolic
reprogramming
of
diverse
cell
types
within
the
tumor
microenvironment
(TME)
is
crucial
for
progression.
While
previous
single-cell
studies
have
identified
a
set
up-
or
down-regulated
pathways,
they
often
overlook
broader
question
how
metabolic
activity
dynamically
allocated
among
competing
processes.
Here
we
present
computational
framework
integrating
multiple
transcriptomic
datasets
human
colorectal
cancer
(CRC)
to
quantify
resource
allocation
strategies
in
TME.
Our
analysis
revealed
cell-type-specific
reallocation
occurring
at
both
global
and
local
levels
mode
regulation
by
novel
signaling
modules,
regulators
(MRRs),
that
occur
specifically
cells,
suggesting
complex
network
signaling-metabolism
crosstalk
during
Activities
these
MRRs
are
significantly
associated
with
biological
clinical
features
tumors,
highlighting
critical
role
By
characterizing
plasticity
TME
its
regulatory
drivers,
this
study
advances
our
understanding
CRC
metabolism
offers
insights
into
precision
medicine
targeting
dependencies.